TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression
-
Published:2024-05-16
Issue:1
Volume:15
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Garcia-Montojo MartaORCID, Fathi SaeedORCID, Rastegar Cyrus, Simula Elena RitaORCID, Doucet-O’Hare TaraORCID, Cheng Y. H. HankORCID, Abrams Rachel P. M.ORCID, Pasternack NicholasORCID, Malik Nasir, Bachani Muzna, Disanza Brianna, Maric DraganORCID, Lee Myoung-Hwa, Wang Herui, Santamaria Ulisses, Li Wenxue, Sampson Kevon, Lorenzo Juan RamiroORCID, Sanchez Ignacio E., Mezghrani AlexandreORCID, Li YanORCID, Sechi Leonardo AntonioORCID, Pineda SebastianORCID, Heiman MyriamORCID, Kellis ManolisORCID, Steiner Joseph, Nath AvindraORCID
Abstract
AbstractTAR DNA-binding protein 43 (TDP-43) proteinopathy in brain cells is the hallmark of amyotrophic lateral sclerosis (ALS) but its cause remains elusive. Asparaginase-like-1 protein (ASRGL1) cleaves isoaspartates, which alter protein folding and susceptibility to proteolysis. ASRGL1 gene harbors a copy of the human endogenous retrovirus HML-2, whose overexpression contributes to ALS pathogenesis. Here we show that ASRGL1 expression was diminished in ALS brain samples by RNA sequencing, immunohistochemistry, and western blotting. TDP-43 and ASRGL1 colocalized in neurons but, in the absence of ASRGL1, TDP-43 aggregated in the cytoplasm. TDP-43 was found to be prone to isoaspartate formation and a substrate for ASRGL1. ASRGL1 silencing triggered accumulation of misfolded, fragmented, phosphorylated and mislocalized TDP-43 in cultured neurons and motor cortex of female mice. Overexpression of ASRGL1 restored neuronal viability. Overexpression of HML-2 led to ASRGL1 silencing. Loss of ASRGL1 leading to TDP-43 aggregation may be a critical mechanism in ALS pathophysiology.
Funder
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke Amyotrophic Lateral Sclerosis Association
Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. del Aguila, M. A., Longstreth, W. T. Jr, McGuire, V., Koepsell, T. D. & van Belle, G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60, 813–819 (2003). 2. Ignatius, S. H., Wu, F., Harrich, D., Garciamartinez, L. F. & Gaynor, R. B. Cloning and characterization of a novel cellular protein, Tdp-43, that binds to human-immunodeficiency-virus type-1 Tar DNA-sequence motifs. J. Virol. 69, 3584–3596 (1995). 3. Ishiguro, T. et al. Regulatory role of RNA chaperone TDP-43 for RNA misfolding and repeat-associated translation in SCA31. Neuron 94, 108–124.e107 (2017). 4. Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602–611 (2006). 5. Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A. & Patel, B. K. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 12, 25 (2019).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|